Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07267871

Oura Blood Pressure Profile Study

The proposed study is designed as a prospective, single-arm, observational, non-significant risk device study to evaluate the performance of Oura's investigational Blood Pressure Profile algorithm in identifying signs of hypertension.

Recruiting

Interested in participating?

Request Info

Key information

Age range

22 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Ouraring

San Francisco, California, 94108, United States

Location status: Recruiting

Location contact

Senior Research Project Manager

CONTACT

[email protected]

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Located in United States
  • Aged 22 years or older at time of eligibility screener
  • Oura Ring user (Oura Ring Gen3 or newer)
  • User of the English version of the Oura App
  • Smartphone (iOS or Android) user
  • Able to provide consent electronically

Exclusion criteria

  • User of implanted cardiac electronic device(s)
  • Currently pregnant
  • Within 12 weeks postpartum

Treatment and study plan

Primary outcomes

  1. Sensitivity of the Oura Blood Pressure Profile classification for identifying participant-reported hypertension

    Time frame: From enrollment until up to 18 months

Secondary outcomes

  1. Specificity of the Oura Blood Pressure Profile classification versus participant-reported hypertension

    Time frame: From enrollment until up to 18 months

Other outcomes

  1. Association between Oura Blood Pressure Profile classification and participant-measured systolic and diastolic blood pressure values

    Time frame: from enrollment until up to 18 months

Sponsors and collaborators

Lead sponsor

Ouraring Inc.

Industry

Registry information

Official study title

Oura Blood Pressure Profile Study: An Evaluation of the Oura Blood Pressure Profile Algorithm for Identifying Signs of Hypertension

Important dates

Study start
2025
Primary completion
2027
Study completion
2027
First posted
Dec 5, 2025
Registry last updated
Apr 13, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.